104 related articles for article (PubMed ID: 2332050)
41. Expression and biochemical characterization of human protein kinase C-theta.
Baier G; Baier-Bitterlich G; Meller N; Coggeshall KM; Giampa L; Telford D; Isakov N; Altman A
Eur J Biochem; 1994 Oct; 225(1):195-203. PubMed ID: 7925438
[TBL] [Abstract][Full Text] [Related]
42. Metallothionein RNA levels in HL-60 cells. Effect of cadmium, differentiation, and protein kinase C activation.
Hanke T; Tyers M; Harley CB
FEBS Lett; 1988 Dec; 241(1-2):159-63. PubMed ID: 3143604
[TBL] [Abstract][Full Text] [Related]
43. Sphinganine potentiation of dimethyl sulfoxide-induced granulocyte differentiation, increase of alkaline phosphatase activity and decrease of protein kinase C activity in a human leukemia cell line (HL-60).
Yung BY; Hsiao TF; Wei LL; Hui EK
Biochem Biophys Res Commun; 1994 Mar; 199(2):888-96. PubMed ID: 8135836
[TBL] [Abstract][Full Text] [Related]
44. Evidence that a novel human differentiation-inhibiting protein blocks the dimethyl sulfoxide-induced differentiation of erythroleukemia cells by inhibiting the activation of membrane protein kinase C.
Durkin JP; Chakravarthy B; Tremblay R; Jouishomme H; Whitfield JF; Biquard JM; Krsmanovic V
Cancer Res; 1992 Nov; 52(22):6329-34. PubMed ID: 1423278
[TBL] [Abstract][Full Text] [Related]
45. Protein kinase C isoenzymes display differential affinity for phorbol esters. Analysis of phorbol ester receptors in B cell differentiation.
Marquez C; Martinez C; Kroemer G; Bosca L
J Immunol; 1992 Oct; 149(8):2560-8. PubMed ID: 1401894
[TBL] [Abstract][Full Text] [Related]
46. A newly characterized human endometrial adenocarcinoma cell line (CAC-1) differentiates in response to retinoic acid treatment.
Carter CA; Madden VJ
Exp Mol Pathol; 2000 Dec; 69(3):175-91. PubMed ID: 11115359
[TBL] [Abstract][Full Text] [Related]
47. Protein kinase C chimeras: catalytic domains of alpha and beta II protein kinase C contain determinants for isotype-specific function.
Walker SD; Murray NR; Burns DJ; Fields AP
Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9156-60. PubMed ID: 7568092
[TBL] [Abstract][Full Text] [Related]
48. The regulatory domain of protein kinase C-epsilon restricts the catalytic-domain-specificity.
Pears C; Schaap D; Parker PJ
Biochem J; 1991 May; 276 ( Pt 1)(Pt 1):257-60. PubMed ID: 2039476
[TBL] [Abstract][Full Text] [Related]
49. Isolation and characterization of the epsilon subspecies of protein kinase C from rat brain.
Koide H; Ogita K; Kikkawa U; Nishizuka Y
Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1149-53. PubMed ID: 1741371
[TBL] [Abstract][Full Text] [Related]
50. Protein kinase C isozymes epsilon and alpha in murine erythroleukemia cells.
Powell CT; Leng L; Dong L; Kiyokawa H; Busquets X; O'Driscoll K; Marks PA; Rifkind RA
Proc Natl Acad Sci U S A; 1992 Jan; 89(1):147-51. PubMed ID: 1729681
[TBL] [Abstract][Full Text] [Related]
51. Expression of protein kinase C subspecies in human leukemia-lymphoma cell lines.
Sawamura S; Ase K; Berry N; Kikkawa U; McCaffrey PG; Minowada J; Nishizuka Y
FEBS Lett; 1989 Apr; 247(2):353-7. PubMed ID: 2785459
[TBL] [Abstract][Full Text] [Related]
52. Differential down-regulation of protein kinase C subspecies in KM3 cells.
Ase K; Berry N; Kikkawa U; Kishimoto A; Nishizuka Y
FEBS Lett; 1988 Aug; 236(2):396-400. PubMed ID: 3410052
[TBL] [Abstract][Full Text] [Related]
53. Protein kinase Calpha expression confers retinoic acid sensitivity on MDA-MB-231 human breast cancer cells.
Cho Y; Talmage DA
Exp Cell Res; 2001 Sep; 269(1):97-108. PubMed ID: 11525643
[TBL] [Abstract][Full Text] [Related]
54. Tissue and cellular distribution of the extended family of protein kinase C isoenzymes.
Wetsel WC; Khan WA; Merchenthaler I; Rivera H; Halpern AE; Phung HM; Negro-Vilar A; Hannun YA
J Cell Biol; 1992 Apr; 117(1):121-33. PubMed ID: 1556149
[TBL] [Abstract][Full Text] [Related]
55. Retinoic acid stimulates the protein kinase C pathway before activation of its beta-nuclear receptor during human teratocarcinoma differentiation.
Kurie JM; Younes A; Miller WH; Burchert M; Chiu CF; Kolesnick R; Dmitrovsky E
Biochim Biophys Acta; 1993 Nov; 1179(2):203-7. PubMed ID: 8218362
[TBL] [Abstract][Full Text] [Related]
56. Translocation and activation of protein kinase C by the plasma cell tumor-promoting alkane pristane.
Janz S; Gawrisch K; Lester DS
Cancer Res; 1995 Feb; 55(3):518-24. PubMed ID: 7834620
[TBL] [Abstract][Full Text] [Related]
57. Expression and characterization of protein kinase C-delta.
Olivier AR; Parker PJ
Eur J Biochem; 1991 Sep; 200(3):805-10. PubMed ID: 1915352
[TBL] [Abstract][Full Text] [Related]
58. Modulation of protein kinase C-epsilon by phorbol esters in the monoblastoid U937 cell.
Ways DK; Messer BR; Garris TO; Qin W; Cook PP; Parker PJ
Cancer Res; 1992 Oct; 52(20):5604-9. PubMed ID: 1394183
[TBL] [Abstract][Full Text] [Related]
59. An antisense oligodeoxynucleotide targeted against the type II beta regulatory subunit mRNA of protein kinase inhibits cAMP-induced differentiation in HL-60 leukemia cells without affecting phorbol ester effects.
Tortora G; Clair T; Cho-Chung YS
Proc Natl Acad Sci U S A; 1990 Jan; 87(2):705-8. PubMed ID: 1689049
[TBL] [Abstract][Full Text] [Related]
60. Purification of PKC-I, an endogenous protein kinase C inhibitor, and types II and III protein kinase C isoenzymes from human neutrophils.
Balazovich KJ; McEwen EL; Lutzke ML; Boxer LA; White T
Biochem J; 1992 Jun; 284 ( Pt 2)(Pt 2):399-405. PubMed ID: 1599424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
